Will Somers, PhD
Vice President, Biomedicines Design, Pfizer
Will Somers completed Post-Doctoral research in Genentech’s Protein Engineering department before joining Genetics Institute in 1994 to set up a new X-ray crystallography group. In Wyeth he went on to lead an expanded group that also included molecular modeling and protein biochemistry that provided protein reagents to groups throughout the company and collaborated with teams on structure based small molecule design. Most recently he headed the Global Biotherapeutic Technologies group at Pfizer that is responsible for discovering and optimizing biotherapeutics in collaboration with all the Research Units. The group has a diverse portfolio consisting of antibodies, antibody drug conjugates and endogenous proteins. One of the groups strengths were the use of innovative structure based engineering techniques that were successfully applied to improve both the potency and properties of therapeutic leads. These methods have contributed to a pipeline of differentiated biotherapeutics that are currently in development.